Dr. Silke Van Genechten SRL

Dr. Silke Van Genechten reported total assets of 87,581 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).

Company number (CBE) 0797.194.597 · VAT BE0797194597
3600 Genk
active in Medical specialists activities (NACE 86220)
operating since 16 Jan 2023 (≈ 3 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Silke Van Genechten shows with a free account.

See the score
Profile
SRL since 2023
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−22,990 €
Equity4,314 €
Cash13,462 €
EBITDA−6,768 €
Total assets87,581 €
The line marks its sector median: 72.2% (8672 companies).

Change 2023 → 2025: Equity -86 % Total assets +18 %

Accounts of the company itself (not consolidated).

The full file covers 3 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Silke Van Genechten's annual accounts

202520242023
Net result−22,990 €
Equity4,314 €
Cash13,462 €
EBITDA−6,768 €
Total assets87,581 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 27 Jul 2026
  • Year ended 31 Dec 2024filed on 29 Aug 2025
  • Year ended 31 Dec 2023filed on 31 Aug 2024

Dr. Silke Van Genechten's financial analysis

Management and control of Dr. Silke Van Genechten

1 active director(s) in the register.

Dr. Silke Van Genechten's shareholders and holdings →

Dr. Silke Van Genechten's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0797.194.597
VAT number
BE0797194597
Peppol
Registered · 0208:0797194597 · as of 10 Nov 2026
Legal form
SRL
Incorporated
16 Jan 2023
Registered office
3600 Genk
Latest accounts
2025 · filed on 27 Jul 2026
Activity
Medical specialists activities (NACE 86220)

Dr. Silke Van Genechten (SRL) has been based in Genk since 2023, active in: medical specialists activities. For 2025, it reports a net loss of 22,990 € and equity of 4,314 €; its revenue is not published. Its solvency stands at 4.9%, below the median of its sector (72.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. Silke Van Genechten

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Silke Van Genechten

What is the revenue of Dr. Silke Van Genechten?

Dr. Silke Van Genechten files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Silke Van Genechten?

In Belgium, the VAT number is the company number prefixed with BE: BE0797194597 for Dr. Silke Van Genechten, if the company is VAT-registered. Its company number (CBE) is 0797.194.597.

Where is the registered office of Dr. Silke Van Genechten?

According to the CBE register, the registered office of Dr. Silke Van Genechten is in 3600 Genk.

What is the equity of Dr. Silke Van Genechten?

At the close of the 2025 financial year, the equity of Dr. Silke Van Genechten amounts to 4,314 €, a solvency of 4.9% of total assets.

Who manages Dr. Silke Van Genechten?

The register lists 1 active mandates at Dr. Silke Van Genechten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. Silke Van Genechten

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Sep 2026

No credit card, no commitment.

What each plan unlocks →